Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Solon Eiendom ASA : Disclosure of large shareholdings - proxies received in connection with EGM

Solon Eiendom ASA
Posted on: 20 Mar 17

Oslo, 20 March 2017: Solon Eiendom ASA (OSE: SOLON).

Simen Thorsen, Chairman of Board, has received proxies to vote for 3 221 515 272 shares at the extraordinary general meeting of Solon Eiendom ASA on 21 March 2017, representing approx. 33,15% of the total shares and votes at the general meeting. The proxies received are only valid for the general meeting and will lapse automatically thereafter.

Simen Thorsen, through his wholly owned company Hortulan AS, owns 2 434 000 000 shares in Solon Eiendom ASA, and may together with the received proxies vote for 5 655 515 272, representing approx. 58,19 % at the extraordinary general meeting.

For further information, please contact:

Andreas Martinussen
Chief Executive Officer, Solon Eiendom ASA
E-mail: Cell Phone: +47 400 00 405

Scott Danielsen
Chief Financial Officer, Solon Eiendom ASA
E-mail: Cell Phone: +47 952 55 620

About Solon Eiendom ASA
Solon Eiendom is a Norwegian residential real estate development company focusing on the Oslo and Akershus region. Solon Eiendom was established in 2006 by founder Simen Thorsen and investor Tore Aksel Voldberg. The company has since its incorporation delivered 570 units with a corresponding sales value of close to NOK ~3 billion and sold more than 800 units with a total sales price of more than NOK ~4 billion.

This information is subject to disclosure pursuant to the Norwegian Securities Trading Act section 4-3 and the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

SEA20170320_Disclosure of large shareholding in EGM

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Solon Eiendom ASA via GlobeNewswire

Last updated on: 21/03/2017

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.